Oat Straw Extract
A 2011 RCT (Berry et al.) found 1600mg green oat extract acutely improved attention and concentration on the Stroop test in healthy adults. A 2017 trial (Kennedy et al.) confirmed dose-dependent improvements in cognitive function and cerebral blood flow at 800mg and 1600mg. Evidence is moderate — fewer trials than top-tier nootropics, but consistently positive for acute attention.
Mecanismo de acción
Oat Straw (Avena sativa) extract works primarily by inhibiting phosphodiesterase type 4 (PDE4) and monoamine oxidase B (MAO-B). PDE4 inhibition increases cyclic AMP levels in neurons, enhancing dopaminergic signalling. MAO-B inhibition slows dopamine breakdown. Additionally, oat straw increases nitric oxide production for cerebral vasodilation and contains avenanthramides — unique anti-inflammatory compounds.
Resumen de evidencia clínica
A 2011 RCT (Berry et al.) found 1600mg green oat extract acutely improved attention and concentration on the Stroop test in healthy adults. A 2017 trial (Kennedy et al.) confirmed dose-dependent improvements in cognitive function and cerebral blood flow at 800mg and 1600mg. Evidence is moderate — fewer trials than top-tier nootropics, but consistently positive for acute attention.
Matriz de efectos en humanos
Based on human clinical trials only. Animal and in-vitro data excluded.
| Efecto | Evidencia | Magnitud | Estudios |
|---|---|---|---|
| Attention & Concentration | moderate | Moderado | 3 |
| Cerebral Blood Flow | moderate | Pequeño | 2 |
| Anxiety Reduction | preliminary | Pequeño | 2 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Beneficios documentados
- Improved attention
- Increased cerebral blood flow
- Mild anxiolytic effect
- Dopamine support via MAO-B inhibition
Efectos secundarios y precauciones
- Generally well tolerated
- Mild GI discomfort rare
- Contains gluten — not suitable for celiac disease
Cómo tomarlo
Recomendaciones de combinación
Ingredientes que se combinan bien con Oat Straw Extract y por qué.
Oat Straw supports dopaminergic signalling via MAO-B; Alpha-GPC supports cholinergic signalling. Complementary neurotransmitter coverage for focus.
Both support dopamine availability — Oat Straw by slowing breakdown (MAO-B), Tyrosine by providing precursor. Synergistic under stress.
Oat Straw provides acute attention benefits; Bacopa provides long-term memory consolidation. Covers both short-term and long-term cognitive needs.
Preguntas frecuentes
Is Oat Straw the same as oatmeal?
No. Oat Straw extract comes from the green, unripe aerial parts of Avena sativa — harvested before the oat grain matures. The active compounds (avenanthramides, saponins) are concentrated in the green straw, not the grain. Eating oatmeal does not provide nootropic effects.
Why is the dose so high (800-1600mg)?
Even at 10:1 concentration, the active compound density in oat straw is lower than more concentrated nootropics like citicoline or huperzine A. The higher dose is needed to reach effective PDE4 inhibition levels. This is typical for herbal extracts.
Does Oat Straw contain gluten?
Oats are technically gluten-free but are commonly cross-contaminated with wheat during processing. If you have celiac disease or severe gluten sensitivity, verify the supplement is certified gluten-free or avoid it entirely.
How does it compare to caffeine for focus?
Oat Straw provides a milder, smoother attention boost without the stimulant side effects of caffeine (no jitteriness, no crash, no tolerance). The effect is subtler — think "clearer attention" rather than "stimulated alertness." Best for users who want focus support without caffeine.
Top stacks containing Oat Straw Extract
Oat Straw Extract en América Latina
Productos disponibles en América Latina
ANVISA / COFEPRIS / INVIMA
Nota regulatoria
Esta página es contenido editorial con fines educativos y no constituye consejo médico. Los suplementos alimenticios están regulados por agencias nacionales: la Agência Nacional de Vigilância Sanitária (ANVISA) en Brasil bajo RDC 243/2018, la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) en México, y el Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) en Colombia. En Argentina, ANMAT Disposición 2105/2022 prohíbe ciertos compuestos nootrópicos (incluyendo Noopept) — no recomendamos productos con esos ingredientes a lectores en Argentina. Aviso para lectores en Brasil: ANVISA publicó en julio de 2026 una alerta oficial advirtiendo que los péptidos inyectables comercializados en línea para bienestar, antienvejecimiento y fitness (incluyendo GHK-Cu, BPC-157, TB-500, CJC-1295 e ipamorelin) no están registrados como medicamentos, suplementos alimentarios ni cosméticos y no pueden venderse legalmente en Brasil. No enlazamos ni recomendamos proveedores que realicen envíos de formulaciones inyectables a Brasil. Consulte siempre a un profesional de la salud calificado antes de comenzar cualquier suplemento. / This page is editorial and not medical advice. Supplements are regulated by national agencies: the Agência Nacional de Vigilância Sanitária (ANVISA) in Brazil, the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico, and the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) in Colombia. In Argentina, ANMAT Disposition 2105/2022 prohibits certain nootropic compounds (including Noopept) — we do not recommend products containing those ingredients to Argentine readers. Brazil notice (updated July 2026): ANVISA issued a formal consumer alert that injectable peptides sold online for wellness, anti-aging, or fitness purposes — including GHK-Cu, BPC-157, TB-500, CJC-1295, and ipamorelin — are unregistered and cannot legally be sold in Brazil. We do not link to or recommend vendors that ship injectable formulations to Brazil. Consult a qualified healthcare professional before starting any supplement.